- Site start-up considerations, such as
- Corporate structure and the corporate practice of medicine
- State-specific licensure considerations
- Provider licensure and supervision requirements
- Payor contracting
- Drug supplier and drug manufacturer relationships and contracting
- Medicare and Medicaid billing and reimbursement policies
- Intra-company considerations related to drug acquisition, staffing, supervision and billing
- Medical director relationships
- Management arrangements and associated contracting
- Mergers and acquisitions
- Joint ventures and collaborations
Ambulatory Infusion Centers & Infusion Pharmacy
Our ambulatory infusion centers and infusion pharmacy attorneys combine deep industry insight and legal understandings of both pharmacy and buy and bill models to advise clients on the complexities of infusion offerings in varied sites of care, including home infusion, ambulatory infusion centers, health system infusion centers, infusion management, and pharmacy infusion. Our attorneys draw upon on experience across all aspects of an infusion business to provide comprehensive and business savvy guidance to clients, including knowledge in supply chain and class of trade issues; payor contracting and billing models; the 340B program; provider licensure and supervision; facility licensure; corporate practice of medicine and associated corporate formation issues of professional corporations; home health licensure and issues related to contractual relationships with nursing agencies; relationships with referral sources, such as medical directors; and joint ventures and collaborations, including joint ventures with hospitals. Our infusion team includes industry veterans who have experience as both in-house general counsel and outside counsel for national infusion pharmacies and pharmacy service providers. Our experience includes matters related to regulatory, corporate, compliance, billing, and contracting issues. We regularly provide guidance to pharmacies, private equity firms, ambulatory infusion suite companies, home infusion companies, and hospitals on topics related to infusion. Our full-service ambulatory infusion centers and infusion pharmacy team counsels clients on a variety of infusion issues, including:
We represented the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible...
We represented OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care,...
We represented Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor...
We represented BioMatrix Specialty Pharmacy, a comprehensive, nationwide specialty pharmacy services and digital health technology solutions provider, in its acquisition...
We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
We represented Consonance Capital Partners, a leading healthcare-focused private equity fund, in the recapitalization of Orsini Pharmaceutical Services, LLC, in...
Bass, Berry & Sims represented Modern HC Holdings, Inc., a specialty pharmacy focused on patients with chronic illnesses, in its...
We represented ModernHC Pharmacy in its acquisition of Infusion Therapy of Texas, a regional home infusion pharmacy. ModernHC Pharmacy is...
We represented Diplomat Pharmacy, Inc. in its acquisition of BioRx, LLC for $350 million in cash and stock. BioRx is...